AUTOIMMUNE HEMOLYTIC ANEMIA

This early-phase study tests a new treatment called RD06-05, which uses specially engineered immune cells (CAR-T cells) to target and destroy the faulty cells causing autoimmune blood diseases. The trial includes 27 adults with conditions like immune thrombocytopenia, autoimmune …

This early-stage study tests the safety of a new drug called CC312 in up to 18 adults with autoimmune diseases like lupus or rheumatoid arthritis that haven't improved with standard treatments. CC312 works like a bridge, guiding the body's immune cells to attack and destroy fault…

This study tests a new drug called CM336 for people with certain blood disorders (like low platelets or anemia) that have come back or not responded to other treatments. The drug works by helping the immune system stop attacking the body's own blood cells. About 158 adults will t…

This study tests whether taking a blood thinner for 12 weeks can prevent dangerous blood clots in people with autoimmune hemolytic anemia (AIHA), a rare disease where the immune system destroys red blood cells. About 72 adults with newly diagnosed or relapsed AIHA will be randoml…

This study is a national registry in France that collects information from adults newly diagnosed with immune thrombocytopenia (ITP) or autoimmune hemolytic anemia (AIHA). The goal is to better understand these rare blood disorders, track how they progress, and evaluate the real-…